Kovach John S 4
4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Dec 2, 2020
Insider Transaction Report
Form 4
Kovach John S
DirectorPresident10% Owner
Transactions
- Purchase
Common Stock
2020-11-30$4.75/sh+21,100$100,225→ 1,540,183 total(indirect: By Trust) - Purchase
Warrants to Purchase Common Stock
2020-11-30$4.75/sh+21,100$100,225→ 21,100 total(indirect: By Trust)Exercise: $5.70From: 2020-11-30Exp: 2025-11-30→ Common (21,100 underlying)
Footnotes (1)
- [F1]The reporting person acquired 21,100 Units, each Unit consisting of one share of Common Stock and a five year warrant at an exercise price of $5.70 per share. The purchase price for a Unit was $4.75 per Unit.